Cetera Advisor Networks’s CorMedix CRMD Stock Holding History

Cetera Advisor Networks’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$51.5K	Hold	12,152	–	–	﹤0.01%	2741
2023 Q4	$45.7K	Buy	+12,152	New	+$41.8K	﹤0.01%	2711

Other funds holding CRMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EIM

Elliott Investment Management West Palm Beach, Florida $22.7B AUM 59.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Cetera Advisor Networks's CRMD Position: Q1 2024 in Review

Cetera Advisor Networks held its CorMedix (CRMD) position steady in Q1 2024 at 12,152 shares worth $51.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2741.

Cetera Advisor Networks first reported a position in CRMD in Q4 2023 and has held it in 2 quarters since. 91 funds tracked by Wall St. Rank hold CRMD as of Q1 2024.

Cetera Advisor Networks held 12,152 shares of CorMedix worth $51.5K as of Q1 2024.
Cetera Advisor Networks left its CorMedix share count unchanged in Q1 2024.
CorMedix made up ﹤0.01% of Cetera Advisor Networks's portfolio in Q1 2024, its #2741 holding.
Cetera Advisor Networks first reported a position in CorMedix in Q4 2023 and has held it in 2 quarters since.
91 funds tracked by Wall St. Rank held CorMedix as of Q1 2024.

Based on Cetera Advisor Networks's 13F filing for Q1 2024, filed 15 May 2024.